Xylem Inc.
XYL
$119.88
-$0.14-0.12%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.04B | 8.89B | 8.73B | 8.60B | 8.56B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.04B | 8.89B | 8.73B | 8.60B | 8.56B |
| Cost of Revenue | 5.56B | 5.49B | 5.43B | 5.37B | 5.35B |
| Gross Profit | 3.48B | 3.40B | 3.30B | 3.23B | 3.21B |
| SG&A Expenses | 1.93B | 1.95B | 1.92B | 1.90B | 1.92B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.72B | 7.67B | 7.58B | 7.50B | 7.50B |
| Operating Income | 1.32B | 1.23B | 1.16B | 1.10B | 1.07B |
| Income Before Tax | 1.18B | 1.19B | 1.16B | 1.11B | 1.09B |
| Income Tax Expenses | 231.00M | 245.00M | 226.00M | 204.00M | 197.00M |
| Earnings from Continuing Operations | 950.00 | 943.00 | 934.00 | 904.00 | 890.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 7.00M | 5.00M | 4.00M | 2.00M | -- |
| Net Income | 957.00M | 948.00M | 938.00M | 906.00M | 890.00M |
| EBIT | 1.32B | 1.23B | 1.16B | 1.10B | 1.07B |
| EBITDA | 1.89B | 1.80B | 1.73B | 1.67B | 1.63B |
| EPS Basic | 3.93 | 3.90 | 3.86 | 3.73 | 3.67 |
| Normalized Basic EPS | 3.41 | 3.15 | 2.94 | 2.79 | 2.69 |
| EPS Diluted | 3.92 | 3.88 | 3.84 | 3.71 | 3.65 |
| Normalized Diluted EPS | 3.40 | 3.14 | 2.93 | 2.78 | 2.68 |
| Average Basic Shares Outstanding | 973.47M | 972.93M | 972.41M | 971.61M | 970.36M |
| Average Diluted Shares Outstanding | 976.02M | 975.54M | 975.20M | 974.80M | 974.04M |
| Dividend Per Share | 1.60 | 1.56 | 1.52 | 1.48 | 1.44 |
| Payout Ratio | 40.86% | 40.08% | 39.55% | 39.74% | 39.33% |